GlassScriptPhysician profile
Amber Garretson
NPI 1457812752
$1,301.43
in general payments reported to CMS, 2019-2025
8 companies · $17.85 in 2025
The $17.85 reported for 2025 was less than what a typical Gerontology (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $161).
See the full distribution for Gerontology (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $394 · 2022: $153 · 2023: $394 · 2024: $343 · 2025: $17.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.31 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $684.47 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Edwards Lifesciences Corporation | $250.00 | 2024 | |
| Inari Medical, INC. | $166.74 | 2021 | |
| Acera Surgical, INC. | $99.81 | 2023-2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $42.11 | 2023-2025 | Watchman Access System, Enroute Transcarotid Neuroprotection System |
| Tactile Systems Technology INC | $27.01 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Kestra Medical Technology Services, INC. | $16.57 | 2023 | Assure Wcd |
| Takeda Pharmaceuticals U.S.A., INC. | $14.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Garretson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.